Abstract: A device for providing multimedia data in a motor vehicle. At least one vehicle-internal hardware component serves to provide a first runtime environment for supporting at least one computer program application on the vehicle-internal hardware component. An interface serves for communication with at least one vehicle-external hardware component, which provides a second runtime environment for supporting the computer program application on the vehicle-external hardware component. Furthermore, either the vehicle-internal hardware component or the vehicle-external hardware component is selectable for executing the computer program application.

Abstract: A switched mode power supply circuit includes a switching converter receiving an input voltage and generating an output voltage from the input voltage in accordance with a switching signal. A switching controller unit is configured to generate the switching signal in accordance with a control parameter set such that the output voltage matches a set-point.

Abstract: A power factor correction (PFC) circuit includes a first inductor, which is operably supplied with an input voltage and an input current. The input voltage is a rectified AC line voltage. A semiconductor switch has a load current path coupled in series with the first inductor. An output terminal is coupled to the inductor and operably providing an output voltage and an output current. A controller circuit controls the cyclic switching operation of the semiconductor switch. The controller circuit is configured to monitor a feedback signal representing the voltage drop across the load current path of the semiconductor switch, to detect at least one local minimum in the feedback signal while the semiconductor switch is off, and to switch on the semiconductor switch in response to detecting the N-th local minimum in the feedback signal.

Abstract: A method for operating a power factor correction circuit is provided which may include the steps of providing a plurality of N switched-mode converter circuits each comprising an nth inductor, where N is at least 2, starting a switching pulse for the nth switched-mode converter circuit when the following conditions are fulfilled: the nth inductor of the nth switched-mode converter circuit has a predefined magnetization state; and a predefined time period has elapsed since the start of a switching pulse for an mth switched-mode converter circuit, where m=n?1 in case n>1 and m=N in case n=1. The predefined time period is a predefined fraction of the time period from the start of a previous switching pulse for the nth switched-mode converter circuit to a time when the nth inductor of the nth switched-mode converter circuit has the predefined magnetization state.

Abstract: A power factor correction circuit is provided which may include a first switched-mode converter circuit comprising a first inductor, at least one second switched-mode converter circuit having a second inductor, a control circuit coupled to the first and second switched-mode converter circuits, wherein the control circuit is configured to start a switching pulse for the second switched-mode converter circuit when the following conditions are fulfilled: the second inductor of the second switched-mode converter circuit has a predefined magnetization state and a predefined time period has elapsed since the start of a switching pulse for the first switched-mode converter circuit, wherein the predefined time period is a predefined fraction of the time period from the start of a previous switching pulse for the second switched-mode converter circuit to a time when the second inductor of the second switched-mode converter circuit has the predefined magnetization state.

Abstract: The sculpture or bendy blanket has a resilient bendable grid frame assembly which allows the sculpture blanket to have all the properties of any blanket and a new aspect of the ability to independently hold usual and unusual forms and shapes. The sculpture blanket is bendable, resilient, able to be sculpted and molded, is formable, adjustable, and able to be articulated into a multitude number of abstract and unusual nonstandard forms for fabric material, and hold its shape until manipulated into a new form by the user; while at the same time provides coziness, warmth, entertainment and protection against environmental elements. The sculpture blanket is resilient, and therefore, constructed using a material that has a property that will allow it to be bent and reformed repeatedly, without damaging the frame, of the frame losing its properties over time to bend or hold the desired shape.

Abstract: In accordance with an embodiment, a power supply controller includes an error signal input configured to be coupled to a sensing node of a power supply, a control output configured to be coupled to a switch control circuit, and a control circuit having an input coupled to the error signal input. The control circuit is configured to provide a first variable limit signal if the error signal input is in a first range, and to adjust the first variable limit signal according to the error signal input.

Abstract: The invention relates to alkynylpyrimidines according to the general formula (I): in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, and salts, N-oxides, metabolites, solvates, tautomers and prodrugs thereof, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.

Abstract: The invention relates to alkynylpyrimidines according to the general formula (I): in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, and salts, N-oxides, metabolites, solvates, tautomers and prodrugs thereof, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.

Abstract: This invention relates to pyrimidine derivatives of general formula I in which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-receptor tyrosine kinases, their production as well as their use as medications for treatment of various diseases.

Abstract: A power factor correction circuit is provided which may include a first switched-mode converter circuit comprising a first inductor, at least one second switched-mode converter circuit having a second inductor, a control circuit coupled to the first and second switched-mode converter circuits, wherein the control circuit is configured to start a switching pulse for the second switched-mode converter circuit when the following conditions are fulfilled: the second inductor of the second switched-mode converter circuit has a predefined magnetization state and a predefined time period has elapsed since the start of a switching pulse for the first switched-mode converter circuit, wherein the predefined time period is a predefined fraction of the time period from the start of a previous switching pulse for the second switched-mode converter circuit to a time when the second inductor of the second switched-mode converter circuit has the predefined magnetization state.

Abstract: A system and method for statistics recording of power devices is disclosed. A power circuit includes a power device to provide a specified electrical power to a load and a host controller coupled to the power device. The host controller is configured to provide issue instructions to and retrieve status information from the power device. A communications and control interface (CCI) is coupled between the power device and the host controller. The CCI is configured to operate as a communications interface between the power device and the host controller and to retrieve and store status information from the power device. The CCI may be capable of performing statistical analysis on the status information to help reduce the amount of information exchanged between the host controller and the power device, thereby reducing bandwidth requirements.

Abstract: This invention provides novel dihydropyridine derivatives of the formula I having protein tyrosine kinase inhibitory activity, to process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions.

Abstract: A transmitter is configured to transmit a transmit signal modulated according to a first modulation scheme, the first modulation scheme being associated with a set of first constellation points. The transmitter transmits at least a part of the transmit signal based on a subset of the first constellation points, wherein the subset of first constellation points approximates second constellation points of a set of second constellation points associated with a second modulation scheme. The first and second modulation schemes are different from one another.

Abstract: A system and apparatus for establishing whether a received signal frame is an audio signal frame is disclosed. In one embodiment, the system includes a predetermined position in an audio signal frame containing a piece of secondary information for an audio characteristic of the audio data, with a selection device for selecting a succession of bits which is arranged at the predetermined position in the received signal frame. A decision-making device flags the received signal frame as an audio signal frame if the succession of bits represents the piece of secondary information.

Abstract: The invention relates to substituted sulphoximines according to the general formula (I): in which A, E, G, X, R1, R2, R3, R4, R5, R6, R7, R8, m, p, q, are given in the claims, and salts thereof, to pharmaceutical compositions comprising said substituted sulphoximines, to methods of preparing said substituted sulphoximines as well as the use thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 signalling.

Abstract: The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.

Abstract: Aza- and polyazanthranyl amides and their use as medicaments in the treatment of diseases caused by persistent angiogenesis are described, as well as the intermediates used in the preparation of the aza- and polyazanthranyl amides.

Abstract: The invention relates to novel nicotinamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.

Abstract: The invention relates to novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors, their production and use as pharmaceutical agents for preventing or treating diseases that are triggered by persistent angiogenesis.